Derek Bagley, Author at Endocrine News

Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment

In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy for clinicians treating postmenopausal women dealing with a loss of bone density. At the beginning of 2024, the U.S. Food and Drug...

The Joy of Endocrinology: Joy Y. Wu, MD, PhD, Breaks the Glass and Bamboo Ceilings

As Endocrine News celebrates Asian American and Pacific Islander Heritage Month, we talk to Joy Y. Wu, MD, PhD, chief of the Division of Endocrinology at Stanford University about her personal and professional journey through the field of endocrinology as well as how her career path has been shaped by her mentors, colleagues, and especially...

First Clinical Trial of Vosoritide for Children with Hypochondroplasia Shows Increased Growth

The first global phase 2 study of vosoritide showed an average increased growth rate of 1.8 cm per year in children with hypochondroplasia, a genetic cause of short stature in children, according to a paper recently published in eClinicalMedicine. The clinical trial is funded by BioMarin. Researchers led by Andrew Dauber, MD, chief of Endocrinology at Children’s...

Obesity

A Relentless Pursuit: JES Invites Collaborative Obesity Research

Three editors of the Journal of the Endocrine Society (JES) recently published an editorial titled “From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology,” recognizing that the landscape of obesity research has rapidly evolved in the past five years, and that sharing scientific data is an important step toward addressing the growing global obesity...

Pandora’s Box? How Artificial Intelligence Could Impact Endocrinology

Like it or not, artificial intelligence (AI) is here to stay, and its impact on both the science and practice of endocrinology will soon be quite evident. The ENDO 2024 Plenary session, “Artificial Intelligence in Health and Biomedical Research: The Future Is Now,” will no doubt answer many questions on the minds of endocrinologists in...

In Touch
- Member News

Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but...

Investigators Describe Changes to Pancreatic Beta-Cell at Onset of Type 1 Diabetes

New research by investigators at Joslin Diabetes Center sheds new light on the specific changes β-cells go through at the onset of type 1 diabetes. Their findings—published in Nature Cell Biology—offer new avenues for targeted interventions for the chronic autoimmune condition. “In the field of type 1 diabetes, research has largely focused on understanding the immune...

Incarceration Nation: Administering Endocrine Healthcare in Our Nation’s Prisons

A first-of-its-kind session at ENDO 2024 will discuss healthcare management for the most underserved of the underserved: the incarcerated. The session, “Endocrine Care for Incarcerated Individuals,” will offer a detailed look at not only what it’s like to be incarcerated, but also the challenges of delivering appropriate endocrine treatment to this often unfairly stigmatized population....